lomefloxacin has been researched along with Conjunctivitis, Bacterial in 5 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
Conjunctivitis, Bacterial: Purulent infections of the conjunctiva by several species of gram-negative, gram-positive, or acid-fast organisms. Some of the more commonly found genera causing conjunctival infections are Haemophilus, Streptococcus, Neisseria, and Chlamydia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The data on the use of the difluoroquinolone lomefloxacin in the treatment of ocular infections such as bacterial conjunctivitis and keratitis, ulcer of the cornea, uveitis, gonococcal and chlamydial conjunctivitis are presented." | 5.08 | [Lomefloxacin in treatment of infectious eye diseases]. ( Kononenko, LA; Maĭchuk, IuF; Vakhova, ES, 1998) |
| "Forty-five patients with presumed acute bacterial conjunctivitis were treated in an investigator-masked randomized multicenter study with either lomefloxacin 0." | 2.68 | Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis. ( Jauch, A; Kari, O; Latvala, ML; Malminiemi, K; Miettinen, A; Voutilainen, R, 1996) |
| "Lomefloxacin eye drops used with a loading dosage followed by a twice daily regimen proved as effective, safe and well tolerated as five established standard treatments used at a 2, 4 or 5 times daily regimen, caused less discomfort upon instillation, and showed a lower risk to generate or select new resistant strains." | 2.40 | Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. ( Fsadni, M; Gamba, G; Jauch, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalil, RM | 1 |
| Abdelbary, GA | 1 |
| Basha, M | 1 |
| Awad, GEA | 1 |
| El-Hashemy, HA | 1 |
| Malminiemi, K | 1 |
| Kari, O | 1 |
| Latvala, ML | 1 |
| Voutilainen, R | 1 |
| Miettinen, A | 1 |
| Jauch, A | 3 |
| Maĭchuk, IuF | 1 |
| Vakhova, ES | 1 |
| Kononenko, LA | 1 |
| Gallenga, PE | 1 |
| Lobefalo, L | 1 |
| Colangelo, L | 1 |
| Della Loggia, G | 1 |
| Orzalesi, N | 1 |
| Velati, P | 1 |
| Bujtar, E | 1 |
| Ponte, F | 1 |
| Damiani, S | 1 |
| Bucci, MG | 1 |
| Bonini, S | 1 |
| Curatola, MR | 1 |
| Palma, LA | 1 |
| Bonomi, L | 1 |
| Tomazzoli Gerosa, L | 1 |
| Pagliarusco, A | 1 |
| Milan, E | 1 |
| Fsadni, M | 1 |
| Gamba, G | 1 |
1 review available for lomefloxacin and Conjunctivitis, Bacterial
| Article | Year |
|---|---|
Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Child; Clinical Trials, Phase III as | 1999 |
3 trials available for lomefloxacin and Conjunctivitis, Bacterial
| Article | Year |
|---|---|
Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Colo | 1996 |
[Lomefloxacin in treatment of infectious eye diseases].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Conjuncti | 1998 |
Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Age | 1999 |
1 other study available for lomefloxacin and Conjunctivitis, Bacterial
| Article | Year |
|---|---|
Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.
Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Cholesterol; Conjunctivitis, Bacterial; D | 2017 |